Back to Journals » OncoTargets and Therapy » Volume 8
Corrigendum
Outcomes analysis of an alternative formulation of PEGylated liposomal doxorubicin in recurrent epithelial ovarian carcinoma during the drug shortage era [Corrigendum]
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
8,269 | Dovepress* | 7,885+ | 1,569 | 9,454 | |
PubMed Central* | 384 | 142 | 526 | ||
Totals | 8,269 | 1,711 | 9,980 | ||
*Since 9 March 2015 +Since July 2016 |
View citations on PubMed and Google Scholar